Alembic Pharmaceuticals announces completion of USFDA inspection at Aleor Dermaceuticals

Alembic Pharmaceuticals announced that Aleor Dermaceuticals (Aleor), a 60:40 Joint Venture between Alembic Pharmaceuticals and Orbicular Pharmaceutical Technologies, has completed United States Food and Drug Administration (USFDA) inspection at its formulation manufacturing facility located at Karakhadi, Gujarat, India; with two observations. The inspection was carried out from 4 February 2019 to 8 February 2019.

Powered by Capital Market - Live News